Orgone Pharmaceuticals Private Limited
About Orgone Pharmaceuticals Private Limited
Data last updated:
Orgone Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the services rendered by liaison offices segment of the business services sector. It was incorporated on 04 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74995BR2016PTC031932. Its GSTIN is 10AACCO3469N1ZB (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Avinash Kumar and Jyoti Srivastava.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 103 Ramchandra Enclave Behind Mitra Mandal Colony Karorichak Phulwarisharif, Patna, Bihar, India – 801505.
As per the financials filed for FY 2020, the company reported a revenue of ₹2.07 Lakh, a growth of 103% compared to the previous year. For the same year it recorded a net loss of ₹2,704 (net margin -1.3%) and EBITDA of -₹2,704 (EBITDA margin -1.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Orgone Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address103 Ramchandra Enclave Behind Mitra Mandal Colony Karorichak Phulwarisharif, Patna, Bihar, India – 801505
- IndustryBusiness Services, Services Rendered By Liaison Offices, Other Services, Miscellaneous Business Activities
To see the full contact details of Orgone Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Orgone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Orgone Pharmaceuticals Private Limited, buy the company report.
Financials of Orgone Pharmaceuticals Private Limited
FY 2020 filings availableOrgone Pharmaceuticals Private Limited reported revenue of ₹2.07 Lakh (up 103% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 103% in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹2.07 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2,704 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2,704 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.3% | |||
| Net Profit Margin | -1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Orgone Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orgone Pharmaceuticals Private Limited
Orgone Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avinash Kumar | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Jyoti Srivastava | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Niharika Jaiswal | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
Peer comparison
Orgone Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mcchem Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2018) | 44.0% | Patna, Bihar, India | |||
| Hoper Pharmaceuticals Private Limited | ₹2.08 Lakh (FY 2020) | Edathala, Kerala, India | ||||
| Fiorallo Pharmaceuticals Private Limited | ₹2.07 Lakh (FY 2024) | -31.0% | Ghaziabad, Uttar Pradesh, India | |||
| Orgone Pharmaceuticals Private Limitedthis company | ₹2.07 Lakh (FY 2020) | -₹2,704 | -1.3% | 103.0% | Patna, Bihar, India |
To see the full peer comparison of Orgone Pharmaceuticals Private Limited, buy the company report.
Auditor
Orgone Pharmaceuticals Private Limited is audited by SHANKARPRASADSAH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHANKARPRASADSAH | FY 2017 | 072232 |
Shareholding
The shareholding of Orgone Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Orgone Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Orgone Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orgone Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Orgone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCO3469N1ZB | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Orgone Pharmaceuticals Private Limited, buy the company report.
Recent activity
Orgone Pharmaceuticals Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Jyoti Srivastava ceased to be Director on 25 Jun 2022.
Frequently asked questions
Orgone Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in services rendered by liaison offices, within the business services industry. It was incorporated on 04 July 2016 (10+ years old) and is registered under CIN U74995BR2016PTC031932.
Orgone Pharmaceuticals has 3 current directors:
- Avinash Kumar - Director
- Jyoti Srivastava - Director
- Niharika Jaiswal - Director
The latest financial statements of Orgone Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Orgone Pharmaceuticals is 10AACCO3469N1ZB, registered in Bihar.
The CIN (Corporate Identification Number) of Orgone Pharmaceuticals is U74995BR2016PTC031932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orgone Pharmaceuticals was incorporated on 04 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Orgone Pharmaceuticals by revenue are Mcchem Pharmaceuticals Private Limited, Hoper Pharmaceuticals Private Limited, Fiorallo Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jyoti Srivastava ceased to be Director on 25 Jun 2022. Avinash Kumar ceased to be Director on 20 Sep 2021. Avinash Kumar was appointed as Director on 04 Jul 2016. Orgone Pharmaceuticals has 5 board changes on record in total.
The registered office of Orgone Pharmaceuticals is at 103 Ramchandra Enclave Behind Mitra Mandal Colony Karorichak Phulwarisharif, Patna, Bihar, India – 801505.
Orgone Pharmaceuticals operates in the business services industry, in the services rendered by liaison offices segment.
The compliance status of Orgone Pharmaceuticals is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.